Category Archives: Tuberculosis (TB)

Cutting Edge: After Covid, can genome sequencing help identify gene responsible for drug-resistant TB?

Posted on April 20, 2022 by donttradeourlivesaway

Tuberculosis is the leading infectious disease killer in the world and was only recently overtaken by Covid-19. Scientists are keen on exploring whole genome sequencing (WGS) for TB investigation. Source: Indian Express In the past two years, genome sequencing enabled … Continue reading →

Posted in COVID-19, Diseases/Therapies, Drugs, Generics, Tuberculosis (TB) | Tagged , | Leave a comment

Shortage of key TB drug stress patients; activists urge govt to issue compulsory license

Posted on October 19, 2021 by donttradeourlivesaway

Source: TimeOfIndia MUMBAI: Stockouts are being reported across the country of a key patented drug, Delaminid, used in drug-resistant tuberculosis (DR-TB), hampering the government’s goal of TB elimination and causing hardship to patients. Much worse, the procurement of the drug … Continue reading →

Posted in Access to Medecines, Access to Medicins, Diseases/Therapies, Generics, Tuberculosis (TB) | Tagged , , , , , | Leave a comment

FDA Approves New Treatment For Drug-Resistant TB; Activists Call For Affordable Access

Posted on August 21, 2019 by donttradeourlivesaway

Source: Health Policy Watch 21st August 2019   The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, more effective course of treatment for highly drug-resistant strains of TB, … Continue reading →

Posted in Access to Medicins, Tuberculosis (TB) | Leave a comment

FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis

Posted on August 19, 2019 by donttradeourlivesaway

Source: Health Policy Watch 19th August, 2019   NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant … Continue reading →

Posted in Tuberculosis (TB) | Leave a comment

Letter to PM on Info Service on Health Issues

Posted on August 13, 2019 by donttradeourlivesaway

Source: Third World Network 13th August, 2019   TWN Info Service on Health Issues (May19/03) 9 May 2019 Third World Network Shri J. P. Nadda Hon’ble Minister of Health and Family Welfare Room No. 348, ‘A’ Wing Nirman Bhavan, New Delhi-110011 … Continue reading →

Posted in Access to Medicins, Tuberculosis (TB) | Leave a comment

Indian civil society pushes for ‘Government Use’ compulsory license on MDR-TB Drugs

Posted on August 13, 2019 by donttradeourlivesaway

Source: Lawyers collective 13th August, 2019   Survivors of drug resistant tuberculosis, health organisations and the TB community in India and across the globe have appealed to the Prime Minister of India to issue a government use compulsory license for two … Continue reading →

Posted in Tuberculosis (TB) | Leave a comment

Civil Society letter to minimize injectables and scale up new drugs in drug-resistant tuberculosis (DR-TB) regimen

Posted on August 13, 2019 by donttradeourlivesaway

13th Aug, 2019   To, Dr. K.S. Sachdeva, Addl DDG, Central TB Division, MoHFW, NirmanBhawan, New Delhi – 110011 Mr. Sanjeeva Kumar, Additional Secy (Health), MoHFW, 254-A, NirmanBhawan, New Delhi – 110011 Prof. Vinod K. Paul, Member, NITI Aayog, Government … Continue reading →

Posted in Tuberculosis (TB) | 1 Comment

Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic

Posted on June 18, 2019 by donttradeourlivesaway

Source: Health Policy Watch 18th June, 2019   Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the … Continue reading →

Posted in Tuberculosis (TB) | Leave a comment

New TB drug reduces treatment time

Posted on May 20, 2019 by donttradeourlivesaway

Source: Health E News 20th May, 2019   A major shot in the arm is set to boost South Africa’s fight against tuberculosis. A grant from the Global Fund is expected to boost the implementation of tuberculosis drug 3HP, a short … Continue reading →

Posted in Tuberculosis (TB) | Leave a comment

FT Health: Fighting humanity’s three biggest infectious diseases

Posted on January 21, 2019 by donttradeourlivesaway

Source: Financial Times 21st Jan 2019 Our guest curator this week is Peter Sands, Executive Director of the Global Fund to Fight Aids, Tuberculosis and Malaria. The best part of my job is going into the field to see health programmes, … Continue reading →

Posted in Access to Medecines, Diseases/Therapies, HIV/Aids, Malaria, Tuberculosis (TB) | Leave a comment